In this regard, our findings revealed that adult mastocytosis patients who suffered from DHRs to NSAIDs or other COXi showed a clear female predominance, which is consistent with previous data reported of a higher risk for DHRs among females36 and more advanced age, when compared with tolerant patients. This evidence concerns the gene MT-CO1 and mastocytosis.